Company
Janssen Biotech, Inc.
20 Case(s) (Last 5 Years)
Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 18000525 | MATERIALS AND METHODS FOR VIRAL PURIFICATION | C12N | May 31, 2021 | |
| 17303425 | Cysteine engineered fibronectin type III domain binding molecules | G01N, A61K, C07K | May 27, 2021 | Jul 17, 2023 |
| 17325743 | Method of Treating Inflammatory Bowel Disease with a Combination Therapy of Antibodies to IL-23 and TNF Alpha | A61P, C07K | May 19, 2021 | |
| 17324148 | Site-specific conjugation of glycosylated monoclonal antibodies with transglutaminase | C07K, C12N, A61K | May 18, 2021 | |
| 17324150 | METHODS FOR SITE SPECIFIC CONJUGATION OF PROTEINS CONTAINING GLYCOSYLATED Fc DOMAINS | A61K, C07K | May 18, 2021 | |
| 17322973 | COMPOSITIONS COMPRISING A T CELL REDIRECTION THERAPEUTIC AND A VLA-4 ADHESION PATHWAY INHIBITOR | A61P, A61K, C07K | May 17, 2021 | |
| 17317789 | Methods for treating multiple myeloma | A61P, A61K, C07K | May 10, 2021 | Apr 8, 2024 |
| 17306572 | PROTOXIN-II VARIANTS AND METHODS OF USE | C07K | May 2, 2021 | Jul 18, 2023 |
| 17243863 | METHODS OF TREATING MULTIPLE MYELOMA | A61K, A61P | Apr 28, 2021 | |
| 17240609 | Materials and Methods for Treating Juvenile Idiopathic Arthritis | A61P, C07K, A61K | Apr 25, 2021 | |
| 17235974 | NEUROLOGIC TOXICITY ASSESSEMENT METHODS AND SYSTEMS FOR DOCUMENTING CHANGES IN HANDWRITING | G16H, A61B | Apr 20, 2021 | |
| 17233021 | BIOSYNTHETIC GLYCOPROTEIN POPULATIONS | C07K | Apr 15, 2021 | |
| 17996099 | TREATMENT OF HIDRADENITIS SUPPURATIVA | C07K, A61P | Apr 15, 2021 | Dec 5, 2023 |
| 17228871 | PSMA AND STEAP1 VACCINES AND THEIR USES | C12N, A61P, A61K | Apr 12, 2021 | |
| 17228753 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING AMINOPYRIMIDINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE, OR SOLVATE THEREOF | A61K | Apr 12, 2021 | |
| 17227632 | INJECTION TRAINING DEVICE AND METHOD FOR USING SAME | G09B | Apr 11, 2021 | |
| 17217393 | Anti-IL6 Agent for Treating Coronavirus Infection | C07K | Mar 29, 2021 | May 11, 2023 |
| 17907235 | ANNOTATING AND MANAGING OF THERAPEUTIC OR BIOLOGICAL DIGITAL DATA | G16B, G16H | Mar 24, 2021 | |
| 17202004 | METHODS AND MATERIALS FOR MODULATING AN IMMUNE RESPONSE | C07K, A61P | Mar 14, 2021 | |
| 17200287 | MATERIALS AND METHODS FOR MODULATING DELTA CHAIN MEDIATED IMMUNITY | C07K | Mar 11, 2021 |